ReviewExpert opinion on investigational drugs2013
Cyclin-dependent kinase inhibitor therapy for hematologic malignancies.
Prithviraj Bose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
73 papers cite itlatest 60 shown
this papercites it